...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - Jan 7, 2016 - Details
With results coming this summer or fall, I like to think we'll hit #5 in my What If post about the same time. Remember Don said with good results the floodgates will open up! I think we'll all be fluffing through silk sooner rather than later!! Jmho PVLee
Share
New Message
Please login to post a reply